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INTRODUCTION
Incidence of epithelial ovarian cancer is around 3%
of all cancers in women worldwide and it ranks the
third among all gynecological cancers. In 2002,
epithelial ovarian cancer contributed to more than
125,000 deaths each year of gynecological cancer.1
Although there has been improvement in the
technique of surgery and chemotherapy, the
prognosis of epithelial ovarian cancer patients was
still poor with 5-year survival rate of 40%. It was
because most of patients generally came at
advanced stage.2,3
Recent studies stated that there was correlation
between genetic transformation causing
malignancy and activation of cancer inflammation
reaction.3 There were many factors that involved
in angiogenesis process correlating to ovarian
cancer, such as inflammatory marker or types of
blood cell. Increased absolute neutrophil, platelet,
and lymphocyte count or neutrophil - lymphocyte
and platelet - lymphocyte ratio had been reported
as one of prognostic factors in ovarian cancer. The
inflammatory response effects on tumor
progression by activating the inflammatory
cytokines that induce cellular DNA damage, inhibit
apoptosis, and trigger the process of angiogenesis
around tumor. This response causes the abnormal
growth, progression, and metastases of tumor.4,5
Therefore, this study aims to determine the
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Objective: To determine the sensitivity and specificity of neutrophil
- lymphocyte ratio compared with platelet - lymphocyte ratio in
predicting ovarian malignancies.
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test design on 37 ovarian tumor patients who were planned to
perform laparotomy in Prof. Dr. R.D. Kandou Hospital Manado and
network hospitals in Manado from March to May 2016. We took
blood samples to assess the complete blood count.
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2.47 as the cut-off point. Meanwhile, the sensitivity and specificity
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as cut-off point.
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Abstrak
Tujuan: Mengetahui sensitivitas dan spesifisitas rasio netrofil -
limfosit dibandingkan rasio trombosit - limfosit dalam memprediksikeganasan ovarium.
Metode: Penelitian ini merupakan penelitian observasional analitikdengan rancang uji diagnostik pada 37 penderita tumor ovarium
yang direncanakan laparotomi di RSUP Prof. Dr. R.D. Kandou Manado
dan rumah sakit jejaring di Manado pada bulan Maret sampai Mei2016. Sampel diambil melalui darah vena untuk dilakukan peme-
riksaan darah lengkap.
Hasil: Didapatkan rerata usia pasien adalah 28,1 tahun (rentang 18-
71 tahun). Sebanyak 13 sampel mengalami keganasan dengan jenishistopatologi terbanyak adalah kistadenokarsinoma musinosum
(27,0%). Nilai sensitivitas dan spesifisitas rasio netrofil - limfosit
adalah 92,3% dan 95,8% dengan titik potong 2,47 dan rasiotrombosit - limfosit adalah 61,5% dan 75,0% dengan titik potong
152,86.
Kesimpulan: Rasio netrofil - limfosit dan rasio trombosit - limfosit
berhubungan dengan keganasan ovarium. Sensitivitas dan spesifisitasrasio netrofil - trombosit menunjukkan hasil yang lebih baik dalam
memprediksi keganasan ovarium.
[Maj Obstet Ginekol Indones 2017; 5-1: 55-59]
Kata kunci: kanker ovarium, rasio netrofil - limfosit, rasio trombosit -
limfosit
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sensitivity and specificity of neutrophil -
lymphocyte ratio compared with platelet -
lymphocyte ratio in predicting ovarian
malignancies
METHODS
This was an observational analytic study with
diagnostic test design. This study was conducted in
the Prof. Dr. R.D. Kandou Hospital Manado and
network hospitals in Manado from March to May
2016. The inclusion criteria were all patients with
ovarian tumors planned to perform laparotomy in
Prof. Dr. R.D. Kandou Hospital Manado and
network hospitals in Manado. Apart from that, the
patients did not show any other malignancies. The
exclusion criteria were patients with other disease
that influenced significant amount of neutrophil,
platelet, lymphocyte and or leukocyte, such as
cardiovascular disease, viral infection, autoimmune
disease, diabetes mellitus, blood disease. We
excluded the patients who did not show the
ovarium tumor as the primary source. We took
intravenous blood sample to assess the complete
blood count so that we could analyze neutrophil -
lymphocyte ratio and platelet - lymphocyte ratio.
Variable of neutrophil - lymphocyte and platelet -
lymphocyte ratio was described in the cross
tabulated table paired with histopathological
result. The analysis of Receiver Operating
Characteristic (ROC) curve was used to calculate
the sensitivity and specificity of neutrophil -
lymphocyte and platelet - lymphocyte ratio to
histopathology examination as the gold standard of
diagnosis. We analyzed through SPSS and p value
of 0.05 was considered statistically significant.
RESULTS
We got 37 ovarian tumor patients who underwent
surgery in Prof. Dr. R.D. Kandou Hospital Manado
and network hospitals in Manado. Table 1 showed
the characteristics of subjects. The mean age of
patients was 40.4 (range 18-71) years old. We
found 20-39 years old as the most prevalent of
ovarian tumor patients in this study (40.5%).
Most of subjects had ever delivery once to twice
(43.2%) and they had normal body mass index
(BMI) (64.8%).
Table 2. Characteristics of Histopathology on Ovarian
      Tumor
Histopathology Profile N %
Benign
Cystadenoma Serosum 5 13.5
Cystadenoma Mucinosum 9 24.3
Dermoid cyst 3 8.1
Hemorrhagic Cyst 7 18.9
Malignant
Cystadenocarsinoma Serosum 3 8.1
Cystadenocarsinoma Mucinosum 10 27.0
Of the 37 cases, we found the malignant cyst
adenocarcinoma mucinosum as many as 10
patients (27.0%) and cystadenocarcinoma
serosum as many as 3 patients (8.1%). While most
were benign ovarian tumor of cystadenoma
mucinosum (24.3%), cystadenoma serosum
(13.5%), hemorrhagic ovarian cysts (18.9%), and
the least number of dermoid cyst (8.1%).
Table 1. The Characteristics of Subjects
Characteristics N % Range (min­max) Mean
Age <20 3 8.1 18.3
20-39 15 40.5 18-71 28.1
40-59 12 32.4 47.4
 60 7 18.9 64.3
Parity 0 10 27.0 0
1-2 16 43.2 0-5 1.6
3-5 11 29.7 3.4
BMI  18 3 8.1 15.8
18-24 24 64.8 16.4-34.5 21.4
25 10 27.0 30.6
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In the Shapiro-Wilk normality test due to small
sample size, we indicated that the data of both
neutrophil - lymphocyte ratio and platelet -
lymphocyte ratio in benign and malignant ovarian
tumors were normally distributed (p>0.05). Thus,
we processed the test into parametric test. The
result of T test showed that there were significant
differences in neutrophil - lymphocyte also platelet
- lymphocyte ratio between patients with benign
and malignant ovarian tumors (p<0.05). It meant
that the ratio of them was associated with ovarian
malignancy.
Of the ROC curve, we obtained area under the
curve (AUC) value of neutrophil - lymphocyte ratio
was 93.1% (p<0.05; 95% CI 80.6-100.0%). Mean-
while, AUC value of platelet - lymphocyte ratio was
60.5% (p=0.022; 95% CI 55.0-91.1%). The analysis
of ROC stated that the optimal sensitivity and
specificity of neutrophil - lymphocyte ratio was
92.3% and 95.8% with a cut-off point on the value
of 2.47. While, the value of optimal sensitivity and
specificity of platelet - lymphocyte ratio was 61.5%
and 75.0% with 152.86 as the cut-off point. Both
ratios were confirmed with histopathology results.
DISCUSSION
Progression and metastases of cancer consist of
cascade steps that involve interaction among
tumor microenvironment, including factors that
contribute to angiogenesis and inflammation. The
capaci ty  of  tumor cel ls  to  invade ,  get
vascularization and metastasis is initiated by a
signal from the primary tumor of micro-
environment, blood vessel, and secondary location
of tumor.6,7 The inflammatory response has
correlation with tumor progression, such as
angiogenesis and tumor invasion through
upregulation of cytokines. In response to the
various  forms of  inf lammation ,  tumor
microenvironment containing innate immune cells
(macrophage, neutrophil, mast cell, dendritic cell,
and natural killer cell) and adaptive immune cells
(lymphocyte T and B) has associated with the
production of cytokines and chemokines and they
act in autocrine and paracrine communication to
organize and establish the growth and progression
tumor.8,9 Systemic inflammation associated with
the release of several pro-inflammatory mediators,
such as IL-1, IL-3 and IL-6 is believed to be able to
stimulate proliferation of megacaryocyte and
Figure 2. Distribution of PLR to Tumor Stage
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Figure 1. Distribution of NLR to Tumor Stage
Figure 3. ROC Curver
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platelet activation that will produce proangiogenic
factor. The proangiogenic factor is essential for
tumor growth. In addition,  a number of
immunological mediators, such as IL-10 and TGF-
are released; they will  cause significant
immunosuppressive effects in order to disrupt
lymphocyte function and reduce the number of
lymphocyte.7,8,10-12 Ovarian cancer is associated
with inflammation that triggers activation of
transcription factors, such as hypoxic-inducing
factor (HIF), signal transducer, activator of
transcription 3 (Stat3), and nuclear factor B (NFB).
These transcription factors result in the production
of chemokines, cytokines and prostaglandins,
which not only produce inflammatory cells, but
also stimulate angiogenesis and cell proliferation.
Anti-inflammatory systemic mediator releases
inhibitors, including IL-10 and TGF-ß, which will
suppress the immune system and reduce the
function of lymphocytes.13-15 Lymphopenia process
has prognostic factor which is associated with poor
outcome of different kind of cancers, such as renal,
pancreatic, and ovarium.7,15-18
In this study, most subjects were 20-39 years
old (40.5%). Aziz MF, et al. obtained the ovarian
tumor patients were 20-65 years old; whereas, this
range of age in population was the most common
for ovarian tumor.19
The result of T test showed that both
neutrophil-lymphocyte and platelet - lymphocyte
ratio had association with malignant ovarian tumor
(p<0.05). Yildirim M, et al. stated that there was
strong correlation between neutrophil -
lymphocyte ratio and the process of cancer,
including cancer staging, prognosis and response
to therapy. The ratio of neutrophil - lymphocyte
and neutrophil - lymphocyte is a marker of
inflammation that is effective to predict pre-
operative ovarian cancer. Both of these markers
are cheap, effective, and generally accepted in
predicting malignancy of ovarian tumor.6 The
inflammatory tumor microenvironment plays a
role in cancer growth. Inflammation can increase
the mutation rate and improve the proliferation of
mutated cell. Inflammation is related to cancer
each other. The damage of DNA in cancer cells can
cause more severe inflammation and promote
cancer. Some pro-inflammatory gene products
have been identified of having an important role in
the suppression of apoptosis, proliferation,
angiogenesis, invasion, and metastases.
Raungkaewmanee S, et al. in 2012 conducted
study on platelet - lymphocyte ratio as a prognostic
factor in epithelial ovarian cancer. Several previous
studies reported an increase in absolute neutrophil
and platelet, the decrease of lymphocyte count in
the incidence of cancer.4 Furthermore, in a study
conducted by Asher V, et al. in 2011, cancer
patients increasing platelet - lymphocyte ratio had
worse prognosis. The inflammatory response
affects tumor progression by activating the
inflammatory cytokines that induce cellular DNA
damage, inhibiting apoptosis, and triggering the
process of angiogenesis around tumor. This
causes the abnormal growth of tumor, progression,
and metastases.5
In this study, the ROC curve showed that the
optimal sensitivity and specificity of neutrophil -
lymphocyte ratio was 92.3% and 95.8% with a
cut-off point on the value of 2.47. While, the
optimal sensitivity and specificity of platelet -
lymphocyte ratio was 61.5% and 75.0% with a cut-
off point on the value 152.86. This result had been
compared to histopathology results. We could
conclude that the ratio of neutrophil - lymphocyte
and platelet - lymphocyte had good value for
predicting ovarian malignancies. Neutrophil -
lymphocyte ratio had better marker compared
with platelet - lymphocytes ratio.
According to Yidrim, et al. in 2014, neutrophil -
lymphocyte and platelet - lymphocyte ratio might
be used in combination with Ca-125 because
Ca-125 was believed to have high sensitivity in
differentiating benign and malignant ovarian
tumor. The Ca-125 as screening method remains
the most important; however, the neutrophil -
lymphocyte ratio and the number of neutrophil can
be used in single or combination with Ca-125 to
detect early stage of ovarian tumor.6
CONCLUSION
Both neutrophil - lymphocyte ratio and platelet -
lymphocyte ratio are associated with ovarian
malignancy. The sensitivity and specificity of
neutrophil - platelet ratio shower better prediction
for ovarian malignancies. Both of these markers
are cheap, effective, and generally accepted in
predicting malignancy of ovarian tumor pre-
operatively.
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